Skip to main content
Clinical Trials/NCT02575872
NCT02575872
Completed
Not Applicable

The Effectiveness of a Comprehensive Physical Activity Behavioral Intervention on Underserved Diverse Obese Endometrial Cancer Survivors

Albert Einstein College of Medicine1 site in 1 country30 target enrollmentOctober 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stage IA Uterine Corpus Cancer
Sponsor
Albert Einstein College of Medicine
Enrollment
30
Locations
1
Primary Endpoint
Proportion of participants completing at least 150 minutes of moderate-vigorous physical activity, assessed by the Yale Physical Activity Survey (YPAS)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This randomized clinical trial studies a physical activity behavioral intervention in obese endometrial cancer survivors. Learning about physical activity behavior while participating in a fitness class may help increase physical activity and improve the quality of life of obese endometrial cancer survivors.

Detailed Description

PRIMARY OBJECTIVES: I. To determine the effect of a 12-week behavior/exercise intervention on moderate-vigorous physical activity (\> 150 minutes) among ethnically diverse endometrial cancer survivors. SECONDARY OBJECTIVES: I. To determine the effects of a 12-week behavior/exercise intervention on body composition among ethnically diverse endometrial cancer survivors. TERTIARY OBJECTIVES: I. To determine the effects of a 12-week behavior/exercise intervention for ethnically diverse endometrial cancer survivors on physical function and quality-of-life. II. To determine the most important behavioral variables for predicting physical activity adherence. III. To determine the most significant facilitators and barriers to adherence during the 12-week intervention. IV. To compare the thematic differences between high-adherence and low-adherence participants and qualitatively assess the strengths and weaknesses of the 12-week intervention. OUTLINE: Participants are randomized to 1 of 2 groups GROUP I: Participants partake in 30 minutes of group discussions regarding physical activity behavior followed by 60 minutes of moderate-intensity exercise comprised of 5 minutes warm-up, 25 minutes cardiovascular training, 20 minutes of resistance training exercises using body weight and exercise band, and 10 minutes of cool-down and stretching once weekly for 12 weeks. Participants also complete a brisk walk for 90 minutes per week outside of class for 12 weeks. GROUP II: Participants receive a handout indicating the importance of physical activity and improved nutrition for health outcomes. After 12 weeks, patients are invited to participate in the physical behavior intervention as in Group I. After completion of study, participants are followed up at 12 weeks.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
June 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nicole Nevadunsky

Principal Investigator

Albert Einstein College of Medicine

Eligibility Criteria

Inclusion Criteria

  • Written informed consent form signed and dated by the subject
  • English and/or Spanish speaking
  • History of endometrial cancer stage I-IV \> 6 months \< 5 years, not currently receiving cancer treatment
  • Overweight (body mass index \[BMI\] \>= 30)
  • Eastern Cooperative Oncology Group performance status (PS) of 0 - 2
  • Medically capable of performing moderate intensity exercise

Exclusion Criteria

  • Must not have engaged in a regular (\> 3x/week, physical activity program in the last 6 months)
  • Medical contraindication to exercise

Outcomes

Primary Outcomes

Proportion of participants completing at least 150 minutes of moderate-vigorous physical activity, assessed by the Yale Physical Activity Survey (YPAS)

Time Frame: 12 weeks

Data will be analyzed using Pearson Chi-square test.

Secondary Outcomes

  • Fatigue, assessed by the FACT-Fatigue(Up to 12 weeks)
  • Waist circumference(Up to 12 weeks)
  • Change in ability to perform activities of daily living, assessed with the YPAS(Baseline to 12 weeks)
  • Barrier avoidance/coping, measured using 5 point Likert scales(Up to 12 weeks)
  • Change in sedentary time, assessed with the YPAS(Baseline to 12 weeks)
  • Outcome expectations, measured using 5 point Likert scales(Up to 12 weeks)
  • Physical function score(Up to 12 weeks)
  • Self-regulation, measured using 5 point Likert scales(Up to 12 weeks)
  • BMI(Up to 12 weeks)
  • Exercise efficacy, measured using 5 point Likert scales(Up to 12 weeks)
  • Quality of life, assessed by the Functional Assessment of Cancer Therapy (FACT)-Endometrial Cancer(Up to 12 weeks)
  • Social support, measured using 5 point Likert scales(Up to 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials